The schizogony of malarial parasite is a typical cyclic phenomenon where the different stages of parasite development appear at regular time intervals. Each of the stages is specifically sensitive to different antimalarial drugs. Knowledge of the details of the cycle, drug susceptibility and the pharmacokinetics of drugs, could allow the improvement of drug action by the chronotherapeutic approach: treatment at the time of appearance of the drugsensitive stage with a drug that displays rapid pharmacokinetics. Since murine malarias serve as preferable models for in vivo drug testing, the pharmacokinetics of subcutaneously (sc) administered chloroquine (CQ) were tested in the whole blood of healthy mice and in animals slightly (1.5-3.5 % parasitemia) or heavily infected 
 (Wernsdorfer, 1991) 
INTRODUCTION
Article available at http://www.parasite-journal.org or http://dx.doi. org/10.1051/parasite/1994013219 Consider the following reasoning (Landau et al., 1991) : a) CQ injected (in man) either sc or im.
rapidly appears in the blood, reaching maximal concentration within 30 min. This is followed by a polyexponential decline of drug concentration in the blood. The maximal concentration reached with parenteral administration is at least 5-fold higher than the mean drug level obtained by oral administration and during the slow terminal exponential elimination of the drug, and the duration of the concentration spike at halfmaximal peak concentration is ca. 80 min (White et al., 1987) . b) CQ is demonstrably cytotoxic.
Temporary exposure of parasites to CQ is sufficient to elicit an irreversible and full inhibitory effect, at least on Plasmodium falciparum in culture (Krugliak and Ginsburg, 1991) . c) The trophozoite stage is the one most susceptible to the drug both in murine malarias (Cambie et al., 1991) and in falciparum malaria in vivo (Landau et al., 1992) and in culture (Yayon et al., 1983; Krugliak and Ginsburg. 1991) . while the mature schizont and the merozoite stages (Langreth et al. 1978) are probably not and the ring stage is only partially susceptible (Cambie et al, 1991 samples were taken immediately prior to drug injection. Samples were held on ice till the end of collection and then frozen to -8()°C. CQ concentration in the whole blood samples was determined by HPLC as previously described (Pussard et al., 1986) .
In order to study the effect of parasitemia and para- 
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R
epresentative single experiments are depicted in Figure 1 with the respective best-fit curves.
The results of the pharmacokinetic analyses are compiled in Table I , and simulated curves were and 50 mg/kg, respectively).
The time of drug injection to healthy mice had no effect on pharmacokinetics in as much as the parameters at day and at night were indistinguishable ( High parasitemias had a much more pronounced effect on the pharmacokinetics of CQ : There was a marked and significant increase in t1/2e (p<0.05), the time to peak drug concentration (tmax) and in the values of AUC and Cmax (p<0.01). The AUC in the day-treated mice was more than twice higher than in night-treated mice (p<0.01). I lealthy or infected mice were injected sc with CQ, and blood was sampled at various time intervals and its C content was determined as described in Materials and Methods. The time-dependence was analyzed by non-linear least square analysis and the best fitting parameters were used to generate the continuous curve in each case. All examples are from day-treated animals. A : healthy mouse, 5 mg/kg CQ; B : healthy mouse, 50 mg/kg CQ; C ; slightly parasitized mouse, 5 mg/kg CQ; D ; heavily infected mouse, 5 mg/kg CQ.
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Parasite 1QQ4 1 IIO-OV, Fig. 2. -Pharmacokinetics of CQ in day treated healthy and infected mice. Health(-----), slightly parazited ( ---) and heavily infected (---) mice were given 5 mg/kg CQ sc at noon, and blood samples were collected at different time intervals and analysed for CQ content.
THE PHARMACOKINETICS OF CHLOROQUINE IN MICE : IMPLICATIONS FOR CHRONOTHERA
The pharmacokinetic data for each mouse were retrieved, averaged, and used to reconstruct the time-dependent changes in blood ICQ1. Fig. 3 . -Pharmacokinetics of CQ in night treated healthy and infected mice. Details are given in the legend to Fig. 2 , except that dnig was injected at virtual midnight. Fig. 4 . -Effect of chloroquine dose on the maximal blood drug concentration. Mice, 4 in each group, were injected sc with 5, 10 and SO mg kg chloroquine diphosphate. Blood was sampled and the chloroquine concentration was determined as described in Materials and Methods. The maximal drug concentration was calculated from the derived pharmacokinetic data, and the mean ± SO were plotted against close. The line was obtained by linear regression (r=0.999).
structurally related to amodiaquine, in the rat, the rabbit and the healthy human. Terminal t1/2 were 14.5 hr, 22 hr and 5 days, respectively (Pussard et al., 1988; Verdier et al., 1989) , indicating a correlation between the size of the animal and this parameter.
Since the precise determination of the final t1/2 value depends on the duration of the study, and because in man CQ decay was best fitted according to a 3 exponential model, it is likely that in the present study in which only data up to 120 min were used for the pharmacokinetic analysis, Ke does not represent ter- (Table I ). In a study on humans (including children) slightly infected (1-2 % parasitemia) with P. falciparum, no differences in the Ke and Ka between healthy and sick subjects was observed (Adelusi et al., 1982) . A much higher erythrocyte to plasma distribution of CQ was determined at the beginning of the treatment (25 mg/kg over 3 days), which then decreased in parallel to the drop in parasitemia, indicating the larger drug uptake into infected cells.
Injection of increasing doses of CQ into healthy mice, resulted in a linear increase of peak blood concentrations (Fig. 4) and AUC, but not in a significant parallel increase in Vd, suggesting that the blood compartment may have become saturated, or that metabolization of the drug was enhanced. Mice closed at night can be included in this generalization, suggesting that handling of CQ by the mouse is not affected by the circadian rhythm.
CQ absorption into the blood compartment from sc injection was very rapid, t1/2. ranging from 4 to 6.5
min, compared to about 20 min in malaria patients (White et al., 1987) , with no effect of time of dosing or parasitemia. The apparent half-time of [CQ] decline (t1/2e) in healthy mice is around 40 min, similar to that observed in falciparum malaria patients using a double exponential decay model (White et al.. 1987) .
or >700 min in healthy humans using a triple exponential decay model (Frisk-Holmberg et al., 1984) . et al., 1985) . Both AUC and t1/2e are larger in day-treated mice ( 
